February 14, 2012 9:00 am by Brandon Glenn | 1 Comments
A clinical-stage biotechnology startup that’s developing a therapy for neuromuscular diseases such as muscular dystrophy has received a $250,000 investment from nonprofit economic development group JumpStart.Cleveland-based Milo Biotechnology’s drug candidate ...
Read more